Endocarditis caused by Capnocytophaga ochracea.

Development of techniques for the genetic manipulation of the gliding bacterium Cytophaga johnsonae. J Bacteriol (1996) 1.81

Antimicrobial susceptibilities and beta-lactamase characterization of Capnocytophaga species. Antimicrob Agents Chemother (1992) 1.52

Development of techniques to genetically manipulate members of the genera Cytophaga, Flavobacterium, Flexibacter, and Sporocytophaga. Appl Environ Microbiol (1996) 1.16

In vitro susceptibilities of Capnocytophaga isolates to beta-lactam antibiotics and beta-lactamase inhibitors. Antimicrob Agents Chemother (2000) 1.03

Inguinal lymphadenitis associated with Capnocytophaga bacilli. J Clin Microbiol (1991) 0.79

Prevalence of oropharyngeal beta-lactamase-producing Capnocytophaga spp. in pediatric oncology patients over a ten-year period. BMC Infect Dis (2005) 0.78

Capnocytophaga lung abscess in a patient with metastatic neuroendocrine tumor. J Clin Microbiol (2011) 0.78

Studies of the microbiology of periodontosis. J Periodontol (1976) 4.03

Capnocytophaga: new genus of gram-negative gliding bacteria. III. Physiological characterization. Arch Microbiol (1979) 2.69

Capnocytophaga sepsis: a newly recognised clinical entity in granulocytopenic patients. Lancet (1980) 2.55

Synonymy of strains of Center for Disease Control group DF-1 with species of Capnocytophaga. J Clin Microbiol (1979) 2.29

Detection, identification, and comparison of Capnocytophaga, Bacteroides ochraceus, and DF-1. J Clin Microbiol (1979) 2.02

A neutrophil disorder induced by capnocytophaga, a dental micro-organism. N Engl J Med (1979) 1.84

Antimicrobial susceptibility of Capnocytophaga. Antimicrob Agents Chemother (1981) 1.74

In vitro susceptibility of Capnocytophaga strains to 18 antimicrobial agents. Antimicrob Agents Chemother (1981) 1.56

Septicemia caused by Capnocytophaga in a granulocytopenic patient with glossitis. Arch Intern Med (1980) 1.44

Septicemia due to Capnocytophaga (Bacteroides ocharaceus) in Hodgkin's disease. Ann Intern Med (1979) 1.19

Capnocytophaga ochracea septicemia. J Clin Microbiol (1981) 1.18

Capnocytophaga septicemia. N Engl J Med (1980) 1.07

[Endocarditis caused by capnocytophaga ochracea]. Nouv Presse Med (1982) 1.01

Cervical abscess due to Capnocytophaga ochracea. Pediatr Infect Dis (1983) 0.99

Cross-resistance to nalidixic acid, trimethoprim, and chloramphenicol associated with alterations in outer membrane proteins of Klebsiella, Enterobacter, and Serratia. J Infect Dis (1985) 4.52

Bacterial persistence in streptococcal endocarditis due to thiol-requiring mutants. J Infect Dis (1971) 4.06

Dissemination of the novel plasmid-mediated beta-lactamase CTX-1, which confers resistance to broad-spectrum cephalosporins, and its inhibition by beta-lactamase inhibitors. Antimicrob Agents Chemother (1988) 3.57

Vancomycin-resistant streptococci or Leuconostoc sp. Antimicrob Agents Chemother (1985) 3.57

Mediastinitis due to multiple resistant Corynebacterium xerosis. Clin Infect Dis (1993) 3.14

Use of penicillin-binding proteins for the identification of enterococci. J Gen Microbiol (1986) 2.87

Comparative evaluation of a new beta-lactamase inhibitor, YTR 830, combined with different beta-lactam antibiotics against bacteria harboring known beta-lactamases. Antimicrob Agents Chemother (1986) 2.63

SHV-5, a novel SHV-type beta-lactamase that hydrolyzes broad-spectrum cephalosporins and monobactams. Antimicrob Agents Chemother (1989) 2.60

Chloramphenicol resistance in Streptococcus pneumoniae: enzymatic acetylation and possible plasmid linkage. Antimicrob Agents Chemother (1978) 2.27

Antimicrobial resistance among lower respiratory tract isolates of Streptococcus pneumoniae: results of a 1992-93 western Europe and USA collaborative surveillance study. The Alexander Project Collaborative Group. J Antimicrob Chemother (1996) 2.21

Susceptibility of Nocardia asteroides to 46 antibiotics, including 22 beta-lactams. Antimicrob Agents Chemother (1983) 2.15

Antimicrobial susceptibility of Gemella haemolysans isolated from patients with subacute endocarditis. Eur J Clin Microbiol (1982) 2.01

Antimicrobial resistance in Streptococcus pneumoniae: an epidemiological survey in France, 1970-1990. Clin Infect Dis (1992) 1.93

A transferable kanamycin resistance plasmid isolated from Haemophilus influenzae. Ann Microbiol (Paris) (1975) 1.92

[The natural resistance of staphylococci to methicillin and oxacillin]. Rev Fr Etud Clin Biol (1965) 1.90

Decreased teicoplanin susceptibility of methicillin-resistant strains of Staphylococcus aureus. J Infect Dis (1995) 1.68

Percentages and distributions of teicoplanin- and vancomycin-resistant strains among coagulase-negative staphylococci. Antimicrob Agents Chemother (1990) 1.58

Mechanisms of quinolone resistance in a clinical isolate of Escherichia coli highly resistant to fluoroquinolones but susceptible to nalidixic acid. Antimicrob Agents Chemother (1991) 1.52

Plasmid-mediated resistance to multiple antibiotics in Salmonella typhi. J Infect Dis (1986) 1.50

Effect of clavulanic acid and amoxycillin formulation against beta-lactamase producing Gram-negative bacteria in urinary tract infections. J Antimicrob Chemother (1979) 1.47

In-vitro susceptibility of Nocardia asteroides to 21 beta-lactam antibiotics, in combination with three beta-lactamase inhibitors, and its relationship to the beta-lactamase content. J Antimicrob Chemother (1985) 1.46

The new quinolones and their combinations with other agents for therapy of severe infections. J Antimicrob Chemother (1986) 1.46

Antagonism of the antibacterial action of some penicillins by other penicillins and cephalosporins. J Clin Invest (1975) 1.45

Sch 34343 activity against streptococci and beta-lactam-resistant Enterobacteriaceae. J Antimicrob Chemother (1985) 1.39

Methicillin-resistant staphylococcemia: bacteriological failure of treatment with cephalosporins. Antimicrob Agents Chemother (Bethesda) (1970) 1.38

In vivo and in vitro emergence of simultaneous resistance to both beta-lactam and aminoglycoside antibiotics in a strain of Serratia marcescens. Ann Microbiol (Paris) (1983) 1.36

International comparison of prevalence of resistance to antibiotics. JAMA (1978) 1.34

Involvement of penicillin-binding protein 2 with other penicillin-binding proteins in lysis of Escherichia coli by some beta-lactam antibiotics alone and in synergistic lytic effect of amdinocillin (mecillinam). Antimicrob Agents Chemother (1986) 1.32

Serratia marcescens infections. Infect Control (1986) 1.30

The changing pattern of trimethoprim resistance in Paris, with a review of worldwide experience. Rev Infect Dis (1986) 1.29

Bacteriostatic and bactericidal activity of azithromycin against Haemophilus influenzae. J Antimicrob Chemother (1990) 1.26

N,N-dimethylglycyl-amido derivative of minocycline and 6-demethyl-6-desoxytetracycline, two new glycylcyclines highly effective against tetracycline-resistant gram-positive cocci. Antimicrob Agents Chemother (1994) 1.25

New bacteriological aspects of infective endocarditis. Eur Heart J (1984) 1.22

Epidemiology of quinolone resistance: Europe and North and South America. Drugs (1995) 1.22

Human infections caused by thiamine- or menadione-requiring Staphylococcus aureus. J Clin Microbiol (1978) 1.19

Synergistic activity of trimethoprim-sulfamethoxazole on gram-negative bacilli: observations in vitro and in vivo. J Infect Dis (1973) 1.17

In-vitro activity of azithromycin against various Gram-negative bacilli and anaerobic bacteria. J Antimicrob Chemother (1990) 1.14

Nutritionally deficient streptococci: electron microscopic study of 14 strains isolated in bacterial endocarditis. Ann Microbiol (Paris) (1981) 1.13

Native valve endocarditis caused by Staphylococcus capitis. Eur J Clin Microbiol Infect Dis (1993) 1.13

Therapy for lower respiratory tract infections with imipenem/cilastatin: a review of worldwide experience. Rev Infect Dis (1985) 1.13

Pharmacokinetics of single intravenous and intramuscular doses of cefotetan in normal human volunteers. J Antimicrob Chemother (1983) 1.12

[Drug sensitivity of Haemophilus sp. and transfer of resistance into E. coli (author's transl)]. Pathol Biol (Paris) (1977) 1.11

Synergistic effect of amoxicillin and cefotaxime against Enterococcus faecalis. Antimicrob Agents Chemother (1995) 1.11

Development of resistance to beta-lactam antibiotics with special reference to third-generation cephalosporins. J Antimicrob Chemother (1984) 1.09

In vitro activities of 15 oral beta-lactams against Klebsiella pneumoniae harboring new extended-spectrum beta-lactamases. Antimicrob Agents Chemother (1990) 1.07

[Trimethoprim resistance plasmids: transferability and incompatibility groups (author's transl)]. Ann Microbiol (Paris) (1977) 1.05

Comparative activity of teicoplanin and vancomycin against 400 penicillin susceptible and resistant Streptococcus pneumoniae. The French Study Group. Eur J Clin Microbiol Infect Dis (1994) 1.05

Pharmacokinetics of sodium fusidate after single and repeated infusions and oral administration of a new formulation. J Antimicrob Chemother (1990) 1.04

Mutation of Salmonella paratyphi A conferring cross-resistance to several groups of antibiotics by decreased permeability and loss of invasiveness. Antimicrob Agents Chemother (1988) 1.03

Transfer of amikacin resistance by closely related plasmids in members of the family Enterobacteriaceae isolated in Chile. Antimicrob Agents Chemother (1986) 1.03

Male fertility and positive Chlamydial serology. A study of 61 fertile and 82 subfertile men. J Androl (1987) 0.98

New quinolones in the treatment of joint and bone infections. Rev Infect Dis (1988) 0.97

Clinical and laboratory evaluation of cephalexin in urinary-tract infections. Antimicrob Agents Chemother (Bethesda) (1969) 0.96

A collaborative study of the in-vitro sensitivity to RP 59500 of bacteria isolated in seven hospitals in France. J Antimicrob Chemother (1992) 0.95

Antimicrobial therapy of experimental endocarditis caused by nutritionally variant viridans group streptococci. Antimicrob Agents Chemother (1986) 0.94

Evolution of enzymatic mechanisms of resistance among beta-lactam antibiotics. J Int Med Res (1990) 0.93

Tigemonam activity against clinical isolates of Enterobacteriaceae and Enterobacteriaceae with known mechanisms of resistance to beta-lactam antibiotics. J Antimicrob Chemother (1989) 0.93

Multilaboratory evaluation of an agar diffusion disk susceptibility test for rapidly growing anaerobic bacteria. Rev Infect Dis (1990) 0.93

Suceptibility of aminoglycoside-resistant gram-negative bacilli to amikacin: delineation of individual resistance patterns. J Infect Dis (1976) 0.93

Resistance pattern of anaerobic bacteria isolated in a general hospital during a two-year period. J Antimicrob Chemother (1981) 0.93

In vitro activity of combinations of beta-lactam antibiotics with beta-lactamase inhibitors against cephalosporinase-producing bacteria. Eur J Clin Microbiol Infect Dis (1989) 0.92

[Increased resistance of streptococcus pneumoniae to antibiotics and prevalence of their capsular serotypes (author's transl)]. Pathol Biol (Paris) (1978) 0.92

Antibacterial activity of meropenem against gram-negative bacteria with a permeability defect and against staphylococci. J Antimicrob Chemother (1989) 0.92

["Pseudomonas aeruginosa" beta-lactamases and sensitivity to carbenicillin (author's transl)]. Ann Microbiol (Paris) (1976) 0.91

Laboratory surveillance of synergy between and resistance to trimethoprim and sulfonamides. Rev Infect Dis (1982) 0.91

An evaluation of the bacteriolytic and biochemical properties of ceftiolene (42980RP). J Antimicrob Chemother (1984) 0.90

[Activity of sulbactam and clavulanic acid, alone and combined, on Acinetobacter calcoaceticus]. Ann Microbiol (Paris) (1983) 0.89

Mechanisms of beta-lactam resistance in Haemophilus influenzae. Eur J Clin Microbiol Infect Dis (1988) 0.89

Use of rifampin for the treatment of serious staphylococcal and gram-negative bacillary infections. Rev Infect Dis (1983) 0.88

In-vitro antibacterial activity of cefepime: a multicentre study. J Antimicrob Chemother (1993) 0.87

Spontaneous peritonitis in cirrhotic hospital in-patients: retrospective analysis of 101 cases. Q J Med (1992) 0.87

Activity of imipenem on aerobic bacteria. J Antimicrob Chemother (1983) 0.87

[Kinetics of cefotaxime in healthy subjects (author's transl)]. Nouv Presse Med (1981) 0.86

A seventeen-year epidemiological survey of antimicrobial resistance in pneumococci in two hospitals. J Antimicrob Chemother (1988) 0.85

[Multicenter study of the activity of pefloxacin on bacteria isolated in a hospital milieu]. Rev Med Interne (1986) 0.85

Ciprofloxacin (BAY 09867): clinical evaluation in urinary tract infections due to Pseudomonas aeruginosa. Chemioterapia (1987) 0.84

[Phenotypes of resistance to aminosides and sensitivity of amikacin in hospitals]. Nouv Presse Med (1979) 0.84

Genetic aspects and epidemiologic implications of resistance to trimethoprim. Rev Infect Dis (1982) 0.84

Amikacin-containing regimens for treatment of nocardiosis in immunocompromised patients. Eur J Clin Microbiol (1987) 0.84

[Antibody coated bacteria in urinary sediment (author's transl)]. Pathol Biol (Paris) (1976) 0.83

[Infectious endocarditis due to Listeria monocytogenes and Cephalosporium]. Presse Med (1971) 0.82

Isolation of Eikenella corrodens from human infections: report of six cases. J Infect (1980) 0.82

[Sensitivity of bacteria to antibiotics. Evaluation of a rapid automatic method (author's transl)]. Pathol Biol (Paris) (1978) 0.82

Epidemiology of antibiotic resistance in Haemophilus influenzae. Microb Drug Resist (1995) 0.82

Synergism and antagonism in double beta-lactam antibiotic combinations. Am J Med (1986) 0.82

[Comparative study of six quinolone antibacterials (author's transl)]. Ann Microbiol (Paris) (1977) 0.81

Effective treatment of urinary tract infections. Infection (1980) 0.81

Two-day cefamandole versus five-day cephazolin prophylaxis in 965 total hip replacements. Report of a multicentre double blind randomised trial. Int Orthop (1988) 0.80

[beta-Lactamases of Branhamella catarrhalis and their phenotypic implications]. Res Microbiol (1996) 0.80

[Antibacterial activity of pefloxacin in the urine during the 7 days following a single 800 mg oral dose]. Pathol Biol (Paris) (1989) 0.80

A multinational European survey on the in-vitro activity of rufloxacin and other comparative antibiotics on respiratory and urinary bacterial pathogens. J Antimicrob Chemother (1996) 0.80

Activity of the beta-lactamase inhibitor BRL 42715 against cephalosporinases produced by Enterobacteriaceae. J Antimicrob Chemother (1993) 0.79

Molecular epidemiology of resistance to trimethoprim in enterobacteria isolated in a Parisian hospital. Ann Inst Pasteur Microbiol (1988) 0.79

Appendicitis due to both Streptococcus pneumoniae and Haemophilus influenzae. Eur J Clin Microbiol Infect Dis (1992) 0.79

Strategies in aminoglycoside use and impact upon resistance. Am J Med (1986) 0.79

Evaluation of the MS-2 automated antimicrobial susceptibility testing system: report of a European collaborative study. Eur J Clin Microbiol (1982) 0.79

[Effect of minocycline on Candida albicans. "In vitro" study: comparison with tetracycline]. Pathol Biol (Paris) (1975) 0.78

Pharmacokinetics of amoxycillin/clavulanic acid in serum and ascitic fluid in cirrhotic patients. J Antimicrob Chemother (1989) 0.78

Screening for extended-spectrum cephalosporin resistance in Streptococcus pneumoniae. J Antimicrob Chemother (1994) 0.78

Epidemiological study of Staphylococcus aureus resistance to new quinolones in a university hospital. J Hosp Infect (1991) 0.78